chrisvoncsefalvay/vaers-outcomes huggingface dataset:
mild headache/splitting headache; soreness; soreness/progressive muscle soreness in the posterior chain (shoulder, back, traps); soreness/progressive muscle soreness in the posterior chain (shoulder, back, traps); lack of energy; soreness/progressive muscle soreness in the posterior chain (shoulder, back, traps); This is a spontaneous report from a contactable other healthcare professional (patient). A male patient of an unspecified age (28, unit unknown) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 23Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Patient received first dose of the Covid vaccine on 23Dec2020, initial symptoms include mild headache and soreness. In the next 5 days symptoms got worse, including progressive muscle soreness in the posterior chain (shoulder, back, traps), splitting headache, lack of energy. Got better in the following 5 days. Outcome of events was recovering. This report is considered as non-serious.   Information about batch/lot number has been requested.
flu-like symptoms; lockjaw; "feeling like they were going to die"; Fever; chills; soreness; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS, TRISMUS (lockjaw), FEELING ABNORMAL (feeling like they were going to die), PYREXIA, and CHILLS in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE for an unknown indication.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS, TRISMUS (lockjaw), FEELING ABNORMAL (feeling like they were going to die), PYREXIA, CHILLS, MYALGIA, and FATIGUE. The patient was treated with TYLENOL at an unspecified dose and frequency. On 24-Apr-2021, TRISMUS (lockjaw), FEELING ABNORMAL (feeling like they were going to die), PYREXIA, CHILLS, MYALGIA, and FATIGUE had resolved. At the time of the report, INFLUENZA LIKE ILLNESS outcome was unknown. Not Provided.          Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to US-MODERNATX, INC-MOD-2021-089050, MOD21-081609, US-MODERNATX, INC-MOD-2021-089217. This case was linked to MOD-2021-089055 (Patient Link). Sender's Comments:  US-MODERNATX, INC-MOD-2021-089050: MOD21-081609: US-MODERNATX, INC.-MOD-2021-089217: 2nd dosage case.
Information has been received from a Registered Nurse concerning a 47 year old female patient with seasonal allergies and allergy to codeine who on 21-SEP-2010 was vaccinated in the left deltoid with a 0.5 ml dose of PNEUMOVAX 23 (Lot# 665707/1407Y) (Expiration date: 12-JUN-2011). On 21-SEP-2010, the patient also received a dose of BOOSTRIX in the left deltoid and a dose of FLUZONE in the right deltoid. The nurse reported that on September 2010, the patient experienced soreness in left arm with hives, swelling and redness. The patient reported that she took BENADRYL. There were no laboratory tests or diagnostic studies performed. At the time of the report, the patient had not recovered. The patient sought unspecified medical attention. Follow up information has been received from a registered nurse. It was reported that the patient with allergy to azithromycin (oral), LEVAQUIN, LIPITOR and penicillin was vaccinated IM in the left deltoid with the first dose of PNEUMOVAX 23 (Lot# 665707/1407Y) on 21-SEP-2010. On 21-SEP-2010, the patient also received the first dose of BOOSTRIX (lot number AC52B051AB) IM in the left deltoid and the first dose of FLUZONE (lot number UH214AC) IM in the right deltoid. There was no illness at the time of vaccination. The registered nurse reported that the patient stopped by the office on 27-SEP-2010 and stated she had a reaction to her PNEUMOVAX 23 shot. The patient's arm got red, she had swelling to upper arm and hives to arm. The patient took BENADRYL. No laboratory tests were performed. At the time of the report the patient's outcome was resolving (also reported as recovered). The nurse reported that the upper arm still had a fine rash and blotched to arm. No further information is expected.
3/31/2021 redness, swelling right hand , extended up middle finger up to pip joint and across metacarpals. Duration 4 days. 3 nose bleedsall on 3/31.  Bloodshot right eye, moderate swelling,started   7pm on 3/31, resolved by 4/4/2021
goes from the muscle and to the elbow and is feeling like a tingle; can't even sleep\cannot sleep because it's painful; muscle pain on left arm\pain goes from the muscle and to the elbow\nagging pain  almost like a tooth ache; tired and cannot sleep because it's painful; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (goes from the muscle and to the elbow and is feeling like a tingle), INSOMNIA (can't even sleep\cannot sleep because it's painful), MYALGIA (muscle pain on left arm\pain goes from the muscle and to the elbow\nagging pain  almost like a tooth ache), FATIGUE (tired and cannot sleep because it's painful) and ARTHRALGIA (Joint pain) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No Medical history reported.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (goes from the muscle and to the elbow and is feeling like a tingle), INSOMNIA (can't even sleep\cannot sleep because it's painful), MYALGIA (muscle pain on left arm\pain goes from the muscle and to the elbow\nagging pain  almost like a tooth ache), FATIGUE (tired and cannot sleep because it's painful) and ARTHRALGIA (Joint pain). At the time of the report, PARAESTHESIA (goes from the muscle and to the elbow and is feeling like a tingle), INSOMNIA (can't even sleep\cannot sleep because it's painful), MYALGIA (muscle pain on left arm\pain goes from the muscle and to the elbow\nagging pain  almost like a tooth ache), FATIGUE (tired and cannot sleep because it's painful) and ARTHRALGIA (Joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant Medications were not provided by the reporter. Treatment: cream (muscle relaxant) nothing seemed to work, Arm exercising 800 mg pills.
Site of injection swollen and red; Site of injection swollen and red; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). A 42-year-old male patient received pneumococcal 20-valent conjugate vaccine (diphtheria CRM197 protein) (PREVNAR 20), on 02May2023 at 17:00 as dose 1, single (Batch/Lot number: unknown) at the age of 42 years, in right arm. The patient's relevant medical history included: "Hypercholesterolaemia" (unspecified if ongoing). Concomitant medication(s) included: ATORVASTATIN. Past drug history included: Biaxin, reaction(s): "Allergy". The following information was reported: VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE SWELLING (non-serious) all with onset 04May2023, outcome "recovered" (07May2023) and all described as "Site of injection swollen and red". Therapeutic measures were taken as a result of vaccination site erythema, vaccination site swelling.  The information on the batch/lot number for pneumococcal 20-valent conjugate vaccine (diphtheria CRM197 protein) has been requested and will be submitted if and when received
Rash to neck, arm upper and lower back starting one week following second dose of the vaccine. Patient self-treated with benadryl daily which improved symptoms. When she stopped, the rash returned and worsened on her back.
Felt extremely tired around 7:30pm. Went to bed. Woke up at 6:00am to get kids ready for school, felt intense headache joint pain, and intense cold feeling to the point of shaking. Went to bed again around 7:45 am. Slept most of the day with headache getting worse. Next day symptoms lessened slightly still bad headache and brain fog which I still have as of today but getting better.
Patient developed localized swelling and severe pruritis at site of vaccination. Patient was given NSAIDS and Benadryl with moderate relief.
This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in an unknown number of female subjects were vaccinated with FLULAVAL, (GlaxoSmithKline) during pregnancy. On an unknown date, the subjects received a dose of FLULAVAL (unknown details) and experienced vaccine exposure during an unknown trimester of pregnancy. The gestational age, date of last menstrual period, and the estimated date of delivery were not reported. The reporter stated that they had been administered FLULAVAL in pregnant patients. At the time of reporting, the reporter was not aware of any adverse events. At the time of reporting, the pregnancy was ongoing. Follow-up received on 5 January 2015 by a healthcare professional. This is a prospective pregnancy case. This female subject was enrolled in an open label study. The subject received FLUARIX on an unknown date. On an unknown date, an unknown time after receiving FLUARIX the subject developed vaccine exposure during pregnancy (Non-serious). The outcome of vaccine exposure during pregnancy was unknown. The pregnancy was lost to follow up. Additional information: On 12 October 2014, this case was considered as lost to follow-up.
This spontaneous report was received from a registered nurse and refers to a 12 month old male patient. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 28-NOV-2018, the patient was vaccinated with PROQUAD lot # N035177, expiration date 09-JUL-2019 (route, dose and frequency were not reported) for prophylaxis. On the same date, the patient was vaccinated with VARIVAX lot # R018777, expiration date 01-JUL-2020 (route, dose and frequency were not reported) for prophylaxis. No adverse effects reported.
Metal taste in mouth; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot number: EL9269) via an unspecified route of administration in the left arm on 18Mar2021 at 16:15 (at the age of 37 years old), as a single dose for COVID-19 immunisation. The patient had known allergies to lobsters and shrimps. The medical history of the patient and concomitant medications was not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot number: EL9266) via an unspecified route of administration in the left arm on 25Feb2021 at 16:15 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Mar2021, the patient experienced metallic taste. No therapeutic measures were taken as a result of the events. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event metallic taste was not recovered at the time reporting.   No follow-up attempts are needed. No further information is expected.
During the vaccination noted that the vaccine burned similarly to antibiotic injection and there was a sensation of receiving vaccination in multiple sites on the upper arm. Normal pain in upper arm following vaccination, but the pain did not subside rather increased until I was feeling pain down the back of my arm, through my elbow and wrist and down through my left ring finger. Pain is not constant but present when I try to reach above my shoulder or behind and to my left as in reaching onto the backseat of a car to pick something up. It is consistent when I try to sleep on my left side. Some days are definitely worse than others.
I have a large dent in my left arm from my COVID-19 vaccine which continues to grow in size and pain. No doctor that I have seen can tell me why this happened. The dent is at least 1/2 deep and 2 to 3 inches across on the wide on my left arm.  The pain occurs at sitting and is about a 3 or 4 and when exercising o using my arm it is an 8 to 10.  I have called Janseen and get no answers.  I hope I do not use the use of my arm.
I developed Shingles.   Rash, severe pain, tingling under skin. I visit my named physician.   She diagnosed as such by sight and symptoms.   Prescribed an antiviral medication and lidocaine patches.
This spontaneous report was received from a physician refers to a male patient of unknown age. No medical history or concurrent conditions were reported. On an unspecified date, the patient was vaccinated with PEDVAXHIB (dose, route, strength and lot number not provided). No co-suspect or concomitant therapies were provided. On an unspecified date, the patient received chemotherapy for cancer and now had no antibodies for any of the (unspecified) vaccines he received during childhood. Physician stated that the patient now needs to receive a haemophilus b conjugate vaccine (unspecified). Physician did not state if the patient received PEDVAXHIB in the past or if PEDVAXHIB caused cancer in the patient. Patient sought medical attention. At the time of the report, the outcome of the events was unknown. The causal relationship between the events and PEDVAXHIB was unknown. Upon internal review the event cancer was considered as another important medical event. Additional information has been requested.
Chills; Sweating; Dizzy; Nauseous; Fever; Extreme lethargy.; Severe migrane headache; Pain on right side of neck; 18 hrs after shot I began vomiting. Anything I drank I threw up for the next 24 hrs; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the right arm on 27Apr2021 at 15:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included multivitamins (unspecified), dienogest, ethinylestradiol (LARISSA) and cetirizine hydrochloride (ZYRTEC); all for unknown indication on unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW 0151) via an unspecified route of administration in the right arm on 06Apr2021 at 10:15 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 05:45, the patient experienced severe migraine headache with pain on right side of neck, chills, sweating, dizzy, nauseous, fever and extreme lethargy. On 28Apr2021, 18 hours after shot, the patient began vomiting and threw up everything she drank for the next 24 hrs. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nauseous, severe migraine headache, pain on right side of neck, vomiting, chills, sweating, dizzy, fever and extreme lethargy was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
MASSIVE STROKE; BLOOD CLOTS; This spontaneous report received from a consumer via social media via a company representative concerned a male of unspecified age, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number and expiry date were not reported) 1 total, dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the reporter stated that "my husband ended up with blood clots after the J&J as well. One went to his brain and cause a massive stroke that killed him. He did have other stuff going on so no way to prove it." The patient died of massive stroke. It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the blood clots was not reported. This report was serious (Death, and Other Medically Important Condition).; Sender's Comments: V0. 20220217624-covid-19 vaccine ad26.cov2.s massive stroke, blood clots. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: MASSIVE STROKE
Information has been received from an office manager concerning a 52 year old female patient who on 02-JUN-2009 was vaccinated with VARIVAX (Merck) (lot # 663301/1776X) exp 11-DEC-2010 instead of ZOSTAVAX (Merck). The office manager reported it was just human error and could not have been prevented. It's unknown if the patient had sought any medical attention. The patient was alive and well and experienced no side effects. This is one of several reports from the same source. Additional information has been requested.
I went to bed on 2/25/2021 and woke up the next day and I had body aches, headache and I also woke up with the hives all over my body. My lips was swollen really bad. I am allergic to a lot of things. I call the doctor and we did a Teladoc and she saw how I was looking and she called me in some antibiotics and I took them along with Benadryl. It started to improve two day later.
Swollen and red at injection site, inconsolable crying over 1 hour, warm to touch at injection site, cries more when injection site is moved or touched.
Mother called and stated 3-4 days after receiving vaccines she noticed fever, flu like symptoms and rash. Mother stated that the flu like symptoms have improved and that the generalized rash with itching to body remained and have not improved with the application of creams. advised Mother  to seek medical attention for child at the nearest emergency room or urgent care center. Also provided address and phone number of a local community health center.
headaches; muscle aches; eye pain; clogged ears; sore throat; nasal congestion; nausea; heartburn; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 22-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 26Jun2022 as dose 2, single (Batch/Lot number: unknown) at the age of 22 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Anxiety" (unspecified if ongoing); "COVID-19" (unspecified if ongoing); "Allergy to nickel" (unspecified if ongoing). Concomitant medication(s) included: SERTRALINE; JUNEL. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot number: Unknown, Vaccine location: Left arm), for COVID-19 immunization. The following information was reported: EAR DISCOMFORT (non-serious) with onset 27Jun2022, outcome "not recovered", described as "clogged ears"; EYE PAIN (non-serious) with onset 27Jun2022, outcome "not recovered"; HEADACHE (non-serious) with onset 27Jun2022, outcome "not recovered", described as "headaches"; DYSPEPSIA (non-serious) with onset 27Jun2022, outcome "not recovered", described as "heartburn"; MYALGIA (non-serious) with onset 27Jun2022, outcome "not recovered", described as "muscle aches"; NASAL CONGESTION (non-serious) with onset 27Jun2022, outcome "not recovered"; NAUSEA (non-serious) with onset 27Jun2022, outcome "not recovered"; OROPHARYNGEAL PAIN (non-serious) with onset 27Jun2022, outcome "not recovered", described as "sore throat". Therapeutic measures were not taken as a result of headache, myalgia, eye pain, ear discomfort, oropharyngeal pain, nasal congestion, nausea, dyspepsia. Additional information: The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The facility type vaccine was pharmacy or drug store. On 27Jun2022 (also reported as  following week after receiving dose 2), the patient experienced headaches, muscle aches, eye pain, clogged ears, sore throat, nasal congestion, nausea, and heartburn. Prior to vaccination, the patient was diagnosed as COVID-19. Since the vaccination, the patient had not been tested for COVID-19.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient administered moderna covid vaccine while temperature excursion was ongoing; Patient administered moderna covid vaccine while temperature excursion was ongoing; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patient administered moderna covid vaccine while temperature excursion was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (Patient administered moderna covid vaccine while temperature excursion was ongoing) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient administered moderna covid vaccine while temperature excursion was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (Patient administered moderna covid vaccine while temperature excursion was ongoing). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patient administered moderna covid vaccine while temperature excursion was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (Patient administered moderna covid vaccine while temperature excursion was ongoing) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. The reporter was an internal medicine manager. It was reported that, there had been no power outages that would have impacted the Moderna vaccine. However, the healthcare professional reiterates that because her facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion. The data logger was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022. They were filling out a temperature excursion assessment with the State at this time. It was reported that, no adverse reactions were reported by the patient. The reporter mentioned that the patient had been administered dose while the temperature excursion assessment was ongoing. The reporter also reported that, no adverse reactions were reported by the patient. No treatment medication was reported.
Feeling very dizzy since the shot.  Its very difficult for him to do his normal daily activities such as work